Telomere length is age-dependent and reduced in monocytes of Alzheimer patients

Experimental Gerontology

Volumn 47, Issue 2, 2012, Pages 160-163

  Hochstrasser, Tanja ^a   Marksteiner, Josef ^b   Humpel, Christian ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b Department of Psychiatry ^*  (Austria)

Author keywords

Alzheimer; Blood; Diagnose; Monocyte; Telomere

Indexed keywords

AGE; AGED; ALZHEIMER DISEASE; ARTICLE; CELL COUNT; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HUMAN; HUMAN CELL; MALE; MONOCYTE; NEUROPATHOLOGY; PRIORITY JOURNAL; TELOMERE; TELOMERE LENGTH; TELOMERE SHORTENING;

AGED; AGING; ALZHEIMER DISEASE; ANALYSIS OF VARIANCE; AUSTRIA; CASE-CONTROL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GENETIC MARKERS; HUMANS; INDIVIDUALIZED MEDICINE; MALE; MONOCYTES; NEUROPSYCHOLOGICAL TESTS; TELOMERE; TELOMERE SHORTENING;

EUKARYOTA;

EID: 84856211181     PISSN: 05315565     EISSN: 18736815     Source Type: Journal    
DOI: 10.1016/j.exger.2011.11.012     Document Type: Article

References (22)

1. Allsopp R.C., Vaziri H., Patterson C., Goldstein S., Younglai E.V., Futcher A.B., Greider C.W., Harley C.B. Telomere length predicts replicative capacity of human fibroblasts. Proc. Natl. Acad. Sci. U. S. A. 1992, 89:10114-10118.
2. Baird D.M. Telomeres. Exp. Gerontol. 2006, 41:1223-1227.
3. Burns A., Byrne E.J., Maurer K. Alzheimer's disease. Lancet 2002, 360:163-165.
4. Fiala M., Cribbs D.H., Rosenthal M., Bernard G. Phagocytosis of amyloid-beta and inflammation: two faces of innate immunity in Alzheimer's disease. J. Alzheimers Dis. 2007, 11:457-463.
5. Flanary B.E., Sammons N.W., Nguyen C., Walker D., Streit W.J. Evidence that aging and amyloid promote microglial cell senescence. Rejuvenation Res. 2007, 10:61-74.
6. Floris S., Ruuls S.R., Wierinckx A., van der Pol S.M., Döpp E., van der Meide P.H., Dijkstra C.D., De Vries H.E. Interferon-beta directly influences monocyte infiltration into the central nervous system. J. Neuroimmunol. 2002, 127:69-79.
7. Guan J.Z., Maeda T., Sugano M., Oyama J., Higuchi Y., Suzuki T., Makino N. A percentage analysis of the telomere length in Parkinson's disease patients. J. Gerontol. A Biol. Sci. Med. Sci. 2008, 63:467-473.
8. Hickman S.E., El Khoury J. Mechanisms of mononuclear phagocyte recruitment in Alzheimer's disease. CNS Neurol. Disord. Drug Targets 2010, 9:168-173.
9. Hochstrasser T., Weiss E., Marksteiner J., Humpel C. Soluble cell adhesion molecules in monocytes of Alzheimer's disease and mild cognitive impairment. Exp. Gerontol. 2010, 45:70-74.
10. Honig L.S., Schupf N., Lee J.H., Tang M.X., Mayeux R. Shorter telomeres are associated with mortality in those with APOE epsilon4 and dementia. Ann. Neurol. 2006, 60:181-187.
11. Humpel C. Identifying and validating biomarkers for Alzheimer's disease. Trends Biotechnol. 2011, 29:26-32.
12. Lukens J.N., Van Deerlin V., Clark C.M., Xie S.X., Johnson F.B. Comparisons of telomere lengths in peripheral blood and cerebellum in Alzheimer's disease. Alzheimers Dement. 2009, 5:463-469.
13. Malm T.M., Koistinaho M., Pärepalo M., Vatanen T., Ooka A., Karlsson S., Koistinaho J. Bone-marrow-derived cells contribute to the recruitment of microglial cells in response to beta-amyloid deposition in APP/PS1 double transgenic Alzheimer mice. Neurobiol. Dis. 2005, 18:134-142.
14. Marksteiner J., Kemmler G., Weiss E.M., Knaus G., Ullrich C., Mechtcheriakov S., Oberbauer H., Auffinger S., Hinterhölzl J., Hinterhuber H., Humpel C. Five out of 16 plasma signaling proteins are enhanced in plasma of patients with mild cognitive impairment and Alzheimer's disease. Neurobiol. Aging 2011, 32:539-540.
15. McKhann G., Drachman D., Folstein M., Katzman R., Price D., Stadlan E.M. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984, 34:939-944.
16. Panossian L.A., Porter V.R., Valenzuela H.F., Zhu X., Reback E., Masterman D., Cummings J.L., Effros R.B. Telomere shortening in T cells correlates with Alzheimer's disease status. Neurobiol. Aging 2003, 24:77-84.
17. Petersen R.C., Doody R., Kurz A., Mohs R.C., Morris J.C., Rabins P.V., Ritchie K., Rossor M., Thal L., Winblad B. Current concepts in mild cognitive impairment. Arch. Neurol. 2001, 58:1985-1992.
18. Reale M., Iarlori C., Feliciani C., Gambi D. Peripheral chemokine receptors, their ligands, cytokines and Alzheimer's disease. J. Alzheimers Dis. 2008, 14:147-159.
19. Tentolouris N., Nzietchueng R., Cattan V., Poitevin G., Lacolley P., Papazafiropoulou A., Perrea D., Katsilambros N., Benetos A. White blood cells telomere length is shorter in males with type 2 diabetes and microalbuminuria. Diabetes Care 2007, 11:2909-29015.
20. Thomas P., O' Callaghan N.J., Fenech M. Telomere length in white blood cells, buccal cells and brain tissue and its variation with ageing and Alzheimer's disease. Mech. Ageing Dev. 2008, 129:183-190.
21. Valdes A.M., Deary I.J., Gardner J., Kimura M., Lu X., Spector T.D., Aviv A., Cherkas L.F. Leukocyte telomere length is associated with cognitive performance in healthy women. Neurobiol. Aging 2010, 31:986-992.
22. von Zglinicki T., Serra V., Lorenz M., Saretzki G., Lenzen-Grossimlighaus R., Gessner R., Risch A., Steinhagen-Thiessen E. Short telomeres in patients with vascular dementia: an indicator of low antioxidative capacity and a possible risk factor?. Lab. Invest. 2000, 80:1739-1747.